2009 Winner of The Dr. Paul Janssen Award for Biomedical Research to be Announced at 6th Annual World Conference of Science Journalists

Saturday, September 19, 2009 General News J E 4

/PRNewswire -- July 1/

WHAT The unveiling of the 2009 winner of The Dr. Paul Janssen Award for Biomedical Research at the upcoming 6th Annual World Conference of Science Journalists. An independent committee of seven of the most esteemed and decorated scientists of our day selected this year's winner from 100-plus top scientists currently contributing to biomedical research. The 2009 winner was chosen for discovering today's most effective ways to approach the treatment of breast cancer and other diseases. WHO Presenters: - 2009 Award winner - Paul Stoffels, M.D., global head, Research & Development, Pharmaceuticals, Johnson & Johnson WHEN Wednesday, July 1 at 4 p.m. BST (8 a.m. PDT/11 a.m. EDT) WHERE William Sangster Room (conference press room) Central Hall Westminster Storey's Gate, London SW1H 9NH Members of the media also may join via teleconference. U.S. dial-in number: 888-285-4585 International dial-in number: 1- 304-345-7354 Participant code: 138005 ABOUT Established by Johnson & Johnson, The Dr. Paul Janssen Award THE salutes the most passionate and creative scientists in basic or AWARD clinical research, whose scientific achievements have made, or have strong potential to make, a measurable impact on human health. The Award - which includes a $100,000 prize - is named for Dr. Paul Janssen, who founded Janssen Pharmaceutica in 1953. Known to his colleagues as "Dr. Paul," Janssen was one of the 20th century's most gifted and passionate researchers, a physician-scientist who helped save millions of lives through his contribution to the discovery and development of more than 80 medicines. CONTACT Brenna Terry Tel: 212-601-8236 E-mail: To learn more about The Dr. Paul Janssen Award for Biomedical Research, please visit

SOURCE Johnson & Johnson


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
XLHealth Appoints New Vice President of Contractin...
Nielsen Announces First-Ever CLIO Healthcare Award...